Full-Time

Total Rewards Lead

Confirmed live in the last 24 hours

Genesis Therapeutics

Genesis Therapeutics

51-200 employees

AI-driven drug discovery for pharmaceuticals

AI & Machine Learning
Biotechnology

Compensation Overview

$170k - $220kAnnually

Senior

Burlingame, CA, USA

Hybrid position in Burlingame, CA.

Category
Financial Analysis
Financial Planning
Accounting
Required Skills
Data Analysis
Requirements
  • Bachelor's degree in Human Resources, Business, or related field is required; Master's degree or relevant certifications (e.g., CCP, GRP) preferred
  • Minimum of 8 years of progressive experience in compensation, with a track record of success in scaling organizations
  • Comfortable working in a fast-paced startup environment that will require you to manage competing priorities, pivot quickly and often, and continually build new processes as the company scales, preferably in an AI Start-up environment
  • Strong understanding of compensation practices, regulations, and market trends
  • Excellent analytical and problem-solving skills, with the ability to use data to drive decision-making
  • Excellent communication and interpersonal skills, with the ability to collaborate effectively with executive leadership and employees
  • Exceptional presentation skills, ability to create and present complex data visually in a clear, concise manner across a variety of audiences
  • Detail-oriented with a high level of accuracy and time management skills
Responsibilities
  • Develop and execute a comprehensive total compensation strategy aligned with the company's objectives and values, ensuring that it supports our scale and growth plans
  • Lead the design, implementation, and maintenance of competitive compensation programs, including base pay, equity incentives, and executive compensation
  • Utilize data analytics and benchmarking to make informed decisions about compensation and benefits, regularly reviewing and adjusting programs to remain competitive
  • Provide thought leadership, and consultation to senior leaders on the development of total rewards methodologies and philosophy, including supporting policies, practices, systems and external partners
  • Supporting Compensation Committee Content: Provides analysis and creates presentation of data to be shared with the Board Compensation Committee, including relevant data analysis and recommendations
  • Stay up-to-date on industry trends, legal requirements, and market dynamics to ensure compliance and relevance of compensation programs
  • Ensure that all compensation and benefits programs comply with relevant laws and regulations, and maintain strong governance practices
  • Partner with finance, people operations, recruitment teams, and executives on pay decisions, compensation process & policies, retention strategies, and job evaluation
  • Develop communication strategies to educate both new and existing employees about their compensation

Genesis Therapeutics focuses on accelerating the development of new medicines using artificial intelligence in the drug discovery sector. The company employs a method that combines 3D spatial graph modeling and advanced molecular simulation to identify potential drug candidates. This approach enables the exploration of new chemical spaces and the discovery of novel protein targets, which can lead to important new medicines. Unlike many competitors, Genesis Therapeutics operates on a business-to-business model, partnering with other biotech and pharmaceutical companies, such as Eli Lilly, to provide its AI-driven drug discovery services. The company generates revenue through upfront payments and potential future earnings based on the success of the drugs developed through its platform. Genesis Therapeutics aims to transform the drug discovery process and bring critical new medicines to market.

Company Stage

N/A

Total Funding

$272.5M

Headquarters

Burlingame, California

Founded

2019

Growth & Insights
Headcount

6 month growth

14%

1 year growth

52%

2 year growth

131%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recognition as a 'Fierce 15' company and one of America's most promising AI companies highlights Genesis Therapeutics' industry leadership and innovation.
  • The $200M Series B funding will enable the company to advance its AI-enabled pipeline into clinical development, potentially leading to groundbreaking new treatments.
  • Partnerships with industry giants like NVIDIA and Eli Lilly provide substantial opportunities for growth and collaboration.

What critics are saying

  • The highly competitive biotech and AI-driven drug discovery sectors may pose challenges in maintaining a unique market position.
  • Dependence on strategic partnerships and funding rounds could impact financial stability if future deals or investments do not materialize.

What makes Genesis Therapeutics unique

  • Genesis Therapeutics leverages a unique combination of 3D spatial graph modeling and advanced molecular simulation, setting it apart from traditional drug discovery methods.
  • Their AI platform, GEMS, is capable of generating novel drug-like molecules and making rapid, accurate predictions for challenging targets, which is a significant competitive advantage.
  • Strategic partnerships with major pharmaceutical companies like Eli Lilly and significant funding rounds, including a $200M Series B, underscore their strong market position.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive salary

Equity

Medical, dental, & vision insurance

401(k) program